Back
Rocket Pharmaceuticals Stock Price Chart
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject
Buy
55
RCKT
Rocket Pharmaceuticals
Last Price:
21.54
Seasonality Move:
13.91%
7 Day Trial
ALL ACCESS PASS
$
7
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.02 | Sell |
| 20-day SMA: | 22.22 | Sell |
| 50-day SMA: | 22.47 | Sell |
| 200-day SMA: | 24.26 | Sell |
| 8-day EMA: | 22.01 | Sell |
| 20-day EMA: | 22.17 | Sell |
| 50-day EMA: | 22.87 | Sell |
| 200-day EMA: | 23.55 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 45.48 | Sell |
| Chaikin Money Flow: | 2908344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.09 - 22.95) | Sell |
| Bollinger Bands (100): | (22.06 - 27.88) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 21.54 while RCKT 8-day simple moving average is 22.02, which is a Sell signal.
- The stock price of RCKT is 21.54 while Rocket Pharmaceuticals 20-day SMA is 22.22, which makes it a Sell.
- Rocket Pharmaceuticals 50-day simple moving average is 22.47 while RCKT share price is 21.54, making it a Sell technically.
- RCKT stock price is 21.54 and Rocket Pharmaceuticals 200-day simple moving average is 24.26, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Buy
55
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Buy
The current Rocket Pharmaceuticals [RCKT] share price is $21.54. The Score for RCKT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
1.96B
Price in USD:
21.54
Share Volume:
3.03M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
14.89
Buy
55
Rocket Pharmaceuticals (RCKT)
is a Buy
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 21.54 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is not overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 21.54 while RCKT 8-day exponential moving average is 22.01, which is a Sell signal.
- The stock price of RCKT is 21.54 while Rocket Pharmaceuticals 20-day EMA is 22.17, which makes it a Sell.
- Rocket Pharmaceuticals 50-day exponential moving average is 22.87 while RCKT share price is 21.54, making it a Sell technically.
- RCKT stock price is 21.54 and Rocket Pharmaceuticals 200-day simple moving average is 23.55, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.41 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Rocket Pharmaceuticals is a Sell
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 45.48, which suggest Rocket Pharmaceuticals is oversold
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (21.09 - 22.95), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (22.06 - 27.88), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.